Invention Grant
- Patent Title: Compounds as c-Met kinase inhibitors
- Patent Title (中): 化合物作为c-Met激酶抑制剂
-
Application No.: US13227866Application Date: 2011-09-08
-
Publication No.: US08664244B2Publication Date: 2014-03-04
- Inventor: Guoqing Paul Chen
- Applicant: Guoqing Paul Chen
- Applicant Address: US CA Moorpark
- Assignee: Advenchen Pharmaceuticals, LLC
- Current Assignee: Advenchen Pharmaceuticals, LLC
- Current Assignee Address: US CA Moorpark
- Main IPC: A61K31/04
- IPC: A61K31/04 ; C07D215/38
Abstract:
The present invention relates to compounds, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with the inhibition of the protein tyrosine kinase activity of growth factor receptors such as c-Met, thereby making them useful as anticancer agents, to their use as medicaments for use in the production of inhibition of tyrosine kinases reducing effects in warm-blooded animals such as humans.
Public/Granted literature
- US20120123126A1 Compounds As c-Met Kinase Inhibitors Public/Granted day:2012-05-17
Information query
